Skip to main content

Provider

By Jessica Hagen | 02:42 pm | March 28, 2025
The report said the technology has helped reduce clinician burnout while improving documentation quality and the patient experience.
HIMSS25
By HIMSS TV | 11:09 am | March 28, 2025
According to Julia Zarb, Blue x Blue CEO and founder, embracing complexity, developing strong analytical skills and understanding common sensibilities and values can help newcomers succeed in the health IT field.
By Adam Ang | 03:07 am | March 28, 2025
Also, South Korean medical AI companies JLK and Coreline Soft announced recent regulatory approvals in Japan and the United States.
HIMSS25
By HIMSS TV | 04:28 pm | March 27, 2025
Data modernization, transformation, interoperability, the use of the digital health indicator, the importance of collaboration and policy, were on the minds of health leaders at the HIMSS25 Public Health Data Modernization Forum.
By Anthony Vecchione | 03:27 pm | March 27, 2025
The partnership will give customers easy access to GLP-1 class drugs and other anti-obesity medications.  
By Jessica Hagen | 01:41 pm | March 27, 2025
Culina Health announces its first C-suite hire since its inception.
By Jessica Hagen | 12:40 pm | March 27, 2025
The company, spun out of MIT and backed by Define Ventures, GV and Flare Capital Partners, was founded by veteran AI and clinical leaders from MIT, Harvard, Microsoft and Google.
HIMSS25
By HIMSS TV | 11:13 am | March 27, 2025
Josh Wymer of the Missouri Department of Health and Senior Services talks about how his involvement with HIMSS beginning at the chapter level has been instrumental in building his career, including gaining a CPDHTS certification.
HIMSS25
By HIMSS TV | 03:10 pm | March 26, 2025
At the HIMSS25 AI in Healthcare Forum, industry thought leaders gathered to discuss how AI will be transformative and disruptive for the future of healthcare.  
By Anthony Vecchione | 01:04 pm | March 26, 2025
The companies said the aim of the partnership is to address the pressure pathologists face due to the global shortage of pathologists and the increasing number of cancer patients.